Skip to content
PeptideGuideA closer look at the research
← All peptide reviews

Skin biology research

GHK-Cu Research review

What a cell-culture experiment can tell us about skin biology—and what it cannot tell us about visible results.

01 / Context first

The research setting

Human fibroblasts grown in a laboratory, rather than people receiving a cosmetic or injection.

02 / The findings

What the sources found

  • GHK-Cu increased production of certain extracellular-matrix molecules in the selected experiment.

03 / The open questions

Where the evidence stops

  • A cellular response does not establish visible wrinkle reduction or hair regrowth in people.
  • This study cannot establish whether a particular topical or injectable product works.

04 / Safety context

Before drawing conclusions

FDA notes limited human safety data and immune-response concerns for injectable GHK-Cu. Route matters.

These reviews do not provide instructions for self-treatment. Discuss personal medical questions with a qualified clinician.

05 / Go to the originals

Read the sources

Inspect the original research and regulatory context behind this review.

  1. Original research — PubMed abstractStimulation of sulfated glycosaminoglycan synthesis by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. ↗
  2. FDA safety informationCertain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks ↗

Sources checked September 12, 2026. Next editorial review due December 11, 2026.

Read the review methodology →